Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor
March 12, 2019 16:32 ET
|
Aeterna Zentaris Inc.
CHARLESTON, S.C., March 12, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) announced today that its board of directors has formed a special committee of independent...
Aeterna Zentaris Receives European Marketing Clearance for Macimorelin
January 16, 2019 09:03 ET
|
Aeterna Zentaris Inc.
CHARLESTON, S.C., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) announced that the European Medicines Agency (EMA) has granted marketing authorization for...
Aeterna Zentaris Settles Dispute with David Dodd and Philip Theodore
December 21, 2018 17:04 ET
|
Aeterna Zentaris Inc.
CHARLESTON, S.C., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc., (NASDAQ:AEZS) (TSX: AEZS) has settled its previously disclosed litigation in South Carolina and Canada with former officers...
Aeterna Zentaris (AEZS) Receives Positive CHMP Opinion of Macimorelin for Diagnosis of Adult Growth Hormone Deficiency
November 19, 2018 08:00 ET
|
Aeterna Zentaris Inc.
CHARLESTON, S.C., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS), announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
Aeterna Zentaris Reports Third Quarter 2018 Financial and Operating Results
November 06, 2018 18:14 ET
|
Aeterna Zentaris Inc.
CHARLESTON, S.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a biopharmaceutical company engaged in developing and commercializing pharmaceutical products,...
Aeterna Zentaris Settles Dispute with Cogas Consulting, LLC
November 06, 2018 08:00 ET
|
Aeterna Zentaris Inc.
CHARLESTON, S.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) and Cogas Consulting, LLC have amicably resolved their dispute with Aeterna Zentaris Inc. agreeing...
Aeterna Zentaris Announces Novo Nordisk to acquire rights to Macrilen™ in United States and Canada
November 01, 2018 08:00 ET
|
Aeterna Zentaris Inc.
CHARLESTON, S.C., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) announces that it was advised yesterday that Strongbridge BioPharma Plc has signed an agreement...
Aeterna Zentaris to Announce Third Quarter 2018 Financial and Operating Results on November 6, 2018
October 31, 2018 16:05 ET
|
Aeterna Zentaris Inc.
CHARLESTON, S.C., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) will announce its third quarter 2018 financial and operating results after market close on...
Aeterna Zentaris Appoints Leslie Auld as Chief Financial Officer
September 25, 2018 08:00 ET
|
Aeterna Zentaris Inc.
CHARLESTON, S.C., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a biopharmaceutical company engaged in developing and commercializing pharmaceutical products,...
Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results
August 09, 2018 16:19 ET
|
Aeterna Zentaris Inc.
CHARLESTON, S.C., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a biopharmaceutical company engaged in developing and commercializing pharmaceutical products,...